Insider Transactions in Q4 2024 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
72,500
-1.59%
|
$1,522,500
$21.29 P/Share
|
|
Nov 20
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,500
+1.57%
|
$217,500
$3.54 P/Share
|
|
Nov 19
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
98,345
-2.15%
|
$2,065,245
$21.19 P/Share
|
|
Nov 19
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,345
+2.1%
|
$295,035
$3.54 P/Share
|
|
Nov 14
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
44,655
-0.99%
|
$937,755
$21.75 P/Share
|
|
Nov 14
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,655
+0.98%
|
$133,965
$3.54 P/Share
|
|
Nov 13
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
92,500
-2.02%
|
$2,035,000
$22.98 P/Share
|
|
Nov 13
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
92,500
+1.98%
|
$277,500
$3.54 P/Share
|
|
Nov 12
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
262,000
-2.83%
|
$6,026,000
$23.31 P/Share
|
|
Nov 12
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
262,000
+2.73%
|
$786,000
$3.78 P/Share
|
|
Nov 11
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
230,000
-4.89%
|
$5,290,000
$23.55 P/Share
|
|
Nov 11
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
230,000
+4.66%
|
$920,000
$4.01 P/Share
|